Pharmacoeconomics:
Gespeichert in:
| Format: | Buch |
|---|---|
| Sprache: | English |
| Veröffentlicht: |
Edinburgh [u.a.]
Churchill Livingstone
2004
|
| Ausgabe: | 1. publ. |
| Schlagworte: | |
| Online-Zugang: | Table of contents |
| Beschreibung: | Includes bibliographical references and index |
| Beschreibung: | xii, 203 p. ill. |
| ISBN: | 044307240X |
Internformat
MARC
| LEADER | 00000nam a2200000zc 4500 | ||
|---|---|---|---|
| 001 | BV019540468 | ||
| 003 | DE-604 | ||
| 005 | 20050426 | ||
| 007 | t | ||
| 008 | 041103s2004 xxka||| |||| 00||| eng d | ||
| 010 | |a 2003015914 | ||
| 020 | |a 044307240X |9 0-443-07240-X | ||
| 035 | |a (OCoLC)52639324 | ||
| 035 | |a (DE-599)BVBBV019540468 | ||
| 040 | |a DE-604 |b ger |e aacr | ||
| 041 | 0 | |a eng | |
| 044 | |a xxk |c GB | ||
| 049 | |a DE-19 | ||
| 050 | 0 | |a RS100 | |
| 082 | 0 | |a 338.4/73621782 |2 22 | |
| 084 | |a QR 525 |0 (DE-625)142044: |2 rvk | ||
| 245 | 1 | 0 | |a Pharmacoeconomics |c ed. by Tom Walley ... |
| 250 | |a 1. publ. | ||
| 264 | 1 | |a Edinburgh [u.a.] |b Churchill Livingstone |c 2004 | |
| 300 | |a xii, 203 p. |b ill. | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 500 | |a Includes bibliographical references and index | ||
| 650 | 4 | |a Industrie pharmaceutique - Aspect économique | |
| 650 | 4 | |a Médicaments - Coût-efficacité | |
| 650 | 4 | |a Médicaments - Politique gouvernementale | |
| 650 | 4 | |a Économie de la santé | |
| 650 | 4 | |a Drugs |x Cost effectiveness | |
| 650 | 4 | |a Economics, Pharmaceutical | |
| 650 | 4 | |a Medical economics | |
| 650 | 4 | |a Pharmaceutical industry |x Economic aspects | |
| 650 | 4 | |a Pharmaceutical policy | |
| 650 | 0 | 7 | |a Pharmakologie |0 (DE-588)4045687-0 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Kostenanalyse |0 (DE-588)4032580-5 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Kostensenkung |0 (DE-588)4032594-5 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Gesundheitswesen |0 (DE-588)4020775-4 |2 gnd |9 rswk-swf |
| 689 | 0 | 0 | |a Pharmakologie |0 (DE-588)4045687-0 |D s |
| 689 | 0 | 1 | |a Kostenanalyse |0 (DE-588)4032580-5 |D s |
| 689 | 0 | |5 DE-604 | |
| 689 | 1 | 0 | |a Gesundheitswesen |0 (DE-588)4020775-4 |D s |
| 689 | 1 | 1 | |a Kostensenkung |0 (DE-588)4032594-5 |D s |
| 689 | 1 | 2 | |a Pharmakologie |0 (DE-588)4045687-0 |D s |
| 689 | 1 | |5 DE-604 | |
| 700 | 1 | |a Walley, Tom |e Sonstige |4 oth | |
| 856 | 4 | |u http://www.loc.gov/catdir/toc/ecip046/2003015914.html |3 Table of contents | |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-012908816 | ||
Datensatz im Suchindex
| _version_ | 1804132924775202816 |
|---|---|
| any_adam_object | |
| building | Verbundindex |
| bvnumber | BV019540468 |
| callnumber-first | R - Medicine |
| callnumber-label | RS100 |
| callnumber-raw | RS100 |
| callnumber-search | RS100 |
| callnumber-sort | RS 3100 |
| callnumber-subject | RS - Pharmacy |
| classification_rvk | QR 525 |
| ctrlnum | (OCoLC)52639324 (DE-599)BVBBV019540468 |
| dewey-full | 338.4/73621782 |
| dewey-hundreds | 300 - Social sciences |
| dewey-ones | 338 - Production |
| dewey-raw | 338.4/73621782 |
| dewey-search | 338.4/73621782 |
| dewey-sort | 3338.4 873621782 |
| dewey-tens | 330 - Economics |
| discipline | Wirtschaftswissenschaften |
| edition | 1. publ. |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02012nam a2200589zc 4500</leader><controlfield tag="001">BV019540468</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20050426 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">041103s2004 xxka||| |||| 00||| eng d</controlfield><datafield tag="010" ind1=" " ind2=" "><subfield code="a">2003015914</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">044307240X</subfield><subfield code="9">0-443-07240-X</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)52639324</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV019540468</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">aacr</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="044" ind1=" " ind2=" "><subfield code="a">xxk</subfield><subfield code="c">GB</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-19</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RS100</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">338.4/73621782</subfield><subfield code="2">22</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">QR 525</subfield><subfield code="0">(DE-625)142044:</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Pharmacoeconomics</subfield><subfield code="c">ed. by Tom Walley ...</subfield></datafield><datafield tag="250" ind1=" " ind2=" "><subfield code="a">1. publ.</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Edinburgh [u.a.]</subfield><subfield code="b">Churchill Livingstone</subfield><subfield code="c">2004</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">xii, 203 p.</subfield><subfield code="b">ill.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Includes bibliographical references and index</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Industrie pharmaceutique - Aspect économique</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Médicaments - Coût-efficacité</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Médicaments - Politique gouvernementale</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Économie de la santé</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drugs</subfield><subfield code="x">Cost effectiveness</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Economics, Pharmaceutical</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Medical economics</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Pharmaceutical industry</subfield><subfield code="x">Economic aspects</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Pharmaceutical policy</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Pharmakologie</subfield><subfield code="0">(DE-588)4045687-0</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Kostenanalyse</subfield><subfield code="0">(DE-588)4032580-5</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Kostensenkung</subfield><subfield code="0">(DE-588)4032594-5</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Gesundheitswesen</subfield><subfield code="0">(DE-588)4020775-4</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Pharmakologie</subfield><subfield code="0">(DE-588)4045687-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Kostenanalyse</subfield><subfield code="0">(DE-588)4032580-5</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="1" ind2="0"><subfield code="a">Gesundheitswesen</subfield><subfield code="0">(DE-588)4020775-4</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="1"><subfield code="a">Kostensenkung</subfield><subfield code="0">(DE-588)4032594-5</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="2"><subfield code="a">Pharmakologie</subfield><subfield code="0">(DE-588)4045687-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Walley, Tom</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="856" ind1="4" ind2=" "><subfield code="u">http://www.loc.gov/catdir/toc/ecip046/2003015914.html</subfield><subfield code="3">Table of contents</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-012908816</subfield></datafield></record></collection> |
| id | DE-604.BV019540468 |
| illustrated | Illustrated |
| indexdate | 2024-07-09T20:00:33Z |
| institution | BVB |
| isbn | 044307240X |
| language | English |
| lccn | 2003015914 |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-012908816 |
| oclc_num | 52639324 |
| open_access_boolean | |
| owner | DE-19 DE-BY-UBM |
| owner_facet | DE-19 DE-BY-UBM |
| physical | xii, 203 p. ill. |
| publishDate | 2004 |
| publishDateSearch | 2004 |
| publishDateSort | 2004 |
| publisher | Churchill Livingstone |
| record_format | marc |
| spelling | Pharmacoeconomics ed. by Tom Walley ... 1. publ. Edinburgh [u.a.] Churchill Livingstone 2004 xii, 203 p. ill. txt rdacontent n rdamedia nc rdacarrier Includes bibliographical references and index Industrie pharmaceutique - Aspect économique Médicaments - Coût-efficacité Médicaments - Politique gouvernementale Économie de la santé Drugs Cost effectiveness Economics, Pharmaceutical Medical economics Pharmaceutical industry Economic aspects Pharmaceutical policy Pharmakologie (DE-588)4045687-0 gnd rswk-swf Kostenanalyse (DE-588)4032580-5 gnd rswk-swf Kostensenkung (DE-588)4032594-5 gnd rswk-swf Gesundheitswesen (DE-588)4020775-4 gnd rswk-swf Pharmakologie (DE-588)4045687-0 s Kostenanalyse (DE-588)4032580-5 s DE-604 Gesundheitswesen (DE-588)4020775-4 s Kostensenkung (DE-588)4032594-5 s Walley, Tom Sonstige oth http://www.loc.gov/catdir/toc/ecip046/2003015914.html Table of contents |
| spellingShingle | Pharmacoeconomics Industrie pharmaceutique - Aspect économique Médicaments - Coût-efficacité Médicaments - Politique gouvernementale Économie de la santé Drugs Cost effectiveness Economics, Pharmaceutical Medical economics Pharmaceutical industry Economic aspects Pharmaceutical policy Pharmakologie (DE-588)4045687-0 gnd Kostenanalyse (DE-588)4032580-5 gnd Kostensenkung (DE-588)4032594-5 gnd Gesundheitswesen (DE-588)4020775-4 gnd |
| subject_GND | (DE-588)4045687-0 (DE-588)4032580-5 (DE-588)4032594-5 (DE-588)4020775-4 |
| title | Pharmacoeconomics |
| title_auth | Pharmacoeconomics |
| title_exact_search | Pharmacoeconomics |
| title_full | Pharmacoeconomics ed. by Tom Walley ... |
| title_fullStr | Pharmacoeconomics ed. by Tom Walley ... |
| title_full_unstemmed | Pharmacoeconomics ed. by Tom Walley ... |
| title_short | Pharmacoeconomics |
| title_sort | pharmacoeconomics |
| topic | Industrie pharmaceutique - Aspect économique Médicaments - Coût-efficacité Médicaments - Politique gouvernementale Économie de la santé Drugs Cost effectiveness Economics, Pharmaceutical Medical economics Pharmaceutical industry Economic aspects Pharmaceutical policy Pharmakologie (DE-588)4045687-0 gnd Kostenanalyse (DE-588)4032580-5 gnd Kostensenkung (DE-588)4032594-5 gnd Gesundheitswesen (DE-588)4020775-4 gnd |
| topic_facet | Industrie pharmaceutique - Aspect économique Médicaments - Coût-efficacité Médicaments - Politique gouvernementale Économie de la santé Drugs Cost effectiveness Economics, Pharmaceutical Medical economics Pharmaceutical industry Economic aspects Pharmaceutical policy Pharmakologie Kostenanalyse Kostensenkung Gesundheitswesen |
| url | http://www.loc.gov/catdir/toc/ecip046/2003015914.html |
| work_keys_str_mv | AT walleytom pharmacoeconomics |